Subclinical Hyperthyroidism and Cardiovascular Risk: Recommendations for Treatment

Authors

Christopher Palmeiro
Maria I Davila
Mallika Bhat
William Frishman, New York Medical CollegeFollow
Irene A Weiss, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1097/CRD.0b013e318294f6f1

Journal Title

Cardiology in Review

First Page

300

Last Page

308

Document Type

Article

Publication Date

1-1-2013

Department

Medicine

Abstract

Subclinical hyperthyroidism (SHy), the mildest form of hyperthyroidism, is diagnosed in patients having a persistently low or undetectable serum concentration of thyroid-stimulating hormone (TSH) with normal free T4 and T3 concentrations. Although overt hyperthyroidism is associated with an increased risk of adverse cardiovascular outcomes, the cardiovascular risk of SHy is controversial. Multiple studies have demonstrated an increased risk of atrial fibrillation, especially in older individuals with TSH levels

Recommended Citation

Palmeiro, C., Davila, M., Bhat, M., Frishman, W., & Weiss, I. (2013). Subclinical Hyperthyroidism and Cardiovascular Risk: Recommendations for Treatment. Cardiology in Review, 21 (6), 300-308. https://doi.org/10.1097/CRD.0b013e318294f6f1